Malaria Treatment for Newborns Approved by WHO
Introduction
The World Health Organization has approved the first malaria treatment specifically designed for newborn babies. Malaria is a deadly disease that claimed 597,000 lives in 2023, with children under 5 accounting for 76 percent of all malaria deaths in Africa. This new treatment is a significant step forward in the fight against this disease, which primarily affects vulnerable populations in developing countries. With this approval, there is renewed hope for the thousands of newborns who are at risk of contracting malaria.
Current Scenario
Malaria is a preventable and treatable disease, yet it continues to be a major public health concern in many parts of the world. In 2023, the World Health Organization reported that there were 409,000 deaths from malaria in the African region alone. This new treatment, which has been specifically formulated for newborns, will help reduce the staggering number of deaths caused by malaria in this region
